Baxter International Inc (BAX)
33.21
+0.22
(+0.67%)
USD |
NYSE |
Nov 22, 16:00
33.12
-0.09
(-0.27%)
Pre-Market: 20:00
Baxter International Cash from Financing (Quarterly): -146.00M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -146.00M |
June 30, 2024 | -936.00M |
March 31, 2024 | -140.00M |
December 31, 2023 | -2.935B |
September 30, 2023 | -62.00M |
June 30, 2023 | -120.00M |
March 31, 2023 | -372.00M |
December 31, 2022 | -119.00M |
September 30, 2022 | -302.00M |
June 30, 2022 | -469.00M |
March 31, 2022 | -548.00M |
December 31, 2021 | 9.276B |
September 30, 2021 | -324.00M |
June 30, 2021 | -349.00M |
March 31, 2021 | -358.00M |
December 31, 2020 | -1.143B |
September 30, 2020 | -111.00M |
June 30, 2020 | -261.00M |
March 31, 2020 | 1.17B |
December 31, 2019 | -116.00M |
September 30, 2019 | -354.00M |
June 30, 2019 | 730.00M |
March 31, 2019 | 238.00M |
December 31, 2018 | -1.508B |
September 30, 2018 | -287.00M |
Date | Value |
---|---|
June 30, 2018 | -263.00M |
March 31, 2018 | -545.00M |
December 31, 2017 | -298.00M |
September 30, 2017 | -175.00M |
June 30, 2017 | 603.00M |
March 31, 2017 | -37.00M |
December 31, 2016 | -280.00M |
September 30, 2016 | -405.00M |
June 30, 2016 | -149.00M |
March 31, 2016 | 510.00M |
December 31, 2015 | -228.00M |
September 30, 2015 | -4.709B |
June 30, 2015 | 4.072B |
March 31, 2015 | 384.00M |
December 31, 2014 | -275.00M |
September 30, 2014 | -55.00M |
June 30, 2014 | -220.00M |
March 31, 2014 | -852.00M |
December 31, 2013 | -150.00M |
September 30, 2013 | -500.00M |
June 30, 2013 | 2.895B |
March 31, 2013 | -600.00M |
December 31, 2012 | -451.00M |
September 30, 2012 | 460.00M |
June 30, 2012 | -576.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.935B
Minimum
Dec 2023
9.276B
Maximum
Dec 2021
81.75M
Average
-281.50M
Median
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 7.00M |
Haemonetics Corp | -74.80M |
Accuray Inc | -2.173M |
Masimo Corp | -1.60M |
Insulet Corp | 7.80M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 253.00M |
Cash from Investing (Quarterly) | -164.00M |
Free Cash Flow | 391.00M |
Free Cash Flow Per Share (Quarterly) | 0.4473 |
Free Cash Flow to Equity (Quarterly) | 198.00M |
Free Cash Flow to Firm (Quarterly) | 305.91M |
Free Cash Flow Yield | 2.31% |